Management of recurrent Malignant Pleural Effusion: what is the best method?

P. Astoul (Marseille, France)

Source: School Course 2014 - Thoracoscopy and Pleural Techniques
Number: 10
Disease area: Thoracic oncology

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Astoul (Marseille, France). Management of recurrent Malignant Pleural Effusion: what is the best method?. School Course 2014 - Thoracoscopy and Pleural Techniques

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019


EPIToME (Early Pleurodesis via IPC with Talc for Malignant Effusion): Evaluation of a new management algorithm
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019



Role of Biomarkers for Predicting suspecting Malignant Mesothelioma in patients with Pleural Effusion presenting to a tertiary care hospital
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019


Malignant pleural mesothelioma: A retrospective analysis of 32 cases
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Malignant pleural effusions: from the diagnosis to the management
Source: International Congress 2015 – ME2 Malignant pleural effusions: from diagnosis to management
Year: 2015




Malignant pleural effusions: diagnosis and management
Source: International Congress 2017 – PG5 Pleural disease management
Year: 2017


The role of a pleural service in optimising pleural disease management
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

Role of fibulin-3 in the diagnosis of malignant mesothelioma
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Pleural mesothelioma: Our experience in 132 cases
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Efficacy And Safety Of Thoracoscopic Cryobiopsy In Patients With Undiagnosed Exudative Pleural Effusion
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020


Comparison of multiple serum and pleural fluid biomarkers for the diagnosis of Malignant Pleural Mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Thoracoscopy: Outcomes in non-diagnostic procedures
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


The patient perspective of treatment for Malignant Pleural Effusion (MPE)- results of a pilot service-evaluation questionnaire.
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

Recurrent pleural effusion – An unusual diagnosis: A case report
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Pleural effusions after cardiac surgery: Etiology and outcomes
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016


Tuberculous pleural effusion
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013


Tunneled indwelling pleural catheter (TPC) in recurrent malignant pleural effusions: A retrospective study of 230 patients
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014